Life insurance applicants will have access to digital questionnaires for medical information, through an Acenda-EQ Pathology initiative.
Life insurer ClearView has sold its advice business and exited wealth but continues to focus on IFAs as a distribution cornerstone.
The exodus of life/risk advisers has continued to weigh on the life insurance sales with new premiums down 18.5%, according to Dexx&r.
Life/risk claims expert, Col Fullagar, analyses a recent court case involving a TPD claim and concludes intransigence delivers no winners.